Regulation of translation initiation by FRAP/mTOR

Regulation of translation initiation by FRAP/mTOR

2001 | Anne-Claude Gingras, Brian Raught, and Nahum Sonenberg
The regulation of translation initiation by FRAP/mTOR is a critical process in eukaryotic protein synthesis, influencing development, differentiation, cell cycle progression, and apoptosis. Translational control is more rapid than transcriptional modulation and is essential for coordinating gene expression in systems lacking transcriptional regulation, such as reticulocytes and platelets. The initiation phase of translation involves the recruitment of ribosomes to mRNA via eukaryotic translation initiation factors (eIFs), particularly the eIF4F complex, which includes eIF4E, eIF4G, and eIF4A. eIF4E binds to the 5' cap of mRNA, while eIF4A unwinds secondary structures in the 5' untranslated region (5'UTR), allowing ribosome binding. The 40S ribosomal subunit is then recruited to the mRNA, and scanning occurs until an initiation codon is recognized. The activity of eIF4F is regulated by the eIF4E binding proteins (4E-BPs), which compete with eIF4G for binding to eIF4E. Phosphorylation of 4E-BPs by PI3K and FRAP/mTOR signaling modulates their interaction with eIF4E, thereby controlling translation initiation. FRAP/mTOR, a mammalian homolog of the yeast Tor protein, is a key regulator of translation initiation and is involved in nutrient sensing. It is a large protein with a carboxy-terminal region homologous to lipid kinases and is part of the PIKK family. FRAP/mTOR functions as a protein kinase and is regulated by the FKBP12-rapamycin complex, which inhibits its activity. FRAP/mTOR signaling is involved in the regulation of translation initiation factors, including eIF4GI, eIF4B, and 4E-BPs. Phosphorylation of these factors by PI3K and FRAP/mTOR signaling modulates their activity, affecting translation rates. Rapamycin treatment inhibits FRAP/mTOR activity, leading to reduced translation initiation. The effects of rapamycin on translation rates in yeast and mammalian cells have been studied, showing that it inhibits the translation of specific mRNAs, particularly those with structured 5'UTRs. The regulation of translation initiation by FRAP/mTOR is a complex process involving multiple signaling pathways and is essential for cellular responses to nutrient availability and stress.The regulation of translation initiation by FRAP/mTOR is a critical process in eukaryotic protein synthesis, influencing development, differentiation, cell cycle progression, and apoptosis. Translational control is more rapid than transcriptional modulation and is essential for coordinating gene expression in systems lacking transcriptional regulation, such as reticulocytes and platelets. The initiation phase of translation involves the recruitment of ribosomes to mRNA via eukaryotic translation initiation factors (eIFs), particularly the eIF4F complex, which includes eIF4E, eIF4G, and eIF4A. eIF4E binds to the 5' cap of mRNA, while eIF4A unwinds secondary structures in the 5' untranslated region (5'UTR), allowing ribosome binding. The 40S ribosomal subunit is then recruited to the mRNA, and scanning occurs until an initiation codon is recognized. The activity of eIF4F is regulated by the eIF4E binding proteins (4E-BPs), which compete with eIF4G for binding to eIF4E. Phosphorylation of 4E-BPs by PI3K and FRAP/mTOR signaling modulates their interaction with eIF4E, thereby controlling translation initiation. FRAP/mTOR, a mammalian homolog of the yeast Tor protein, is a key regulator of translation initiation and is involved in nutrient sensing. It is a large protein with a carboxy-terminal region homologous to lipid kinases and is part of the PIKK family. FRAP/mTOR functions as a protein kinase and is regulated by the FKBP12-rapamycin complex, which inhibits its activity. FRAP/mTOR signaling is involved in the regulation of translation initiation factors, including eIF4GI, eIF4B, and 4E-BPs. Phosphorylation of these factors by PI3K and FRAP/mTOR signaling modulates their activity, affecting translation rates. Rapamycin treatment inhibits FRAP/mTOR activity, leading to reduced translation initiation. The effects of rapamycin on translation rates in yeast and mammalian cells have been studied, showing that it inhibits the translation of specific mRNAs, particularly those with structured 5'UTRs. The regulation of translation initiation by FRAP/mTOR is a complex process involving multiple signaling pathways and is essential for cellular responses to nutrient availability and stress.
Reach us at info@study.space